NCT02739321

Brief Summary

The purpose of the present study is to evaluate the tolerability and efficacy of the Sound To Sleep System™ in improving the sleep quality of children with Autism Spectrum Disorder (ASD). The Sound To Sleep System™ is a mattress foundation designed to improve sleep quality in individuals with ASD and sleep disturbance by providing mattress vibrations that accompany and sync with auditory stimulation. For the present study, the primary objectives are as follows: \* Study Aim 1 - To determine whether the use of the Sound To Sleep System™ in ASD-affected children with sleep disturbances is well tolerated as defined by group drop-out proportion due to issues with the mattress technology. The study will also explore the following objectives:

  • Study Aim 2 - To determine the efficacy of the Sound To Sleep System™ in improving sleep quality as measured by parent reported sleep quality in ASD-affected children with sleep disturbances. (Please note Study Aim 2 was changed from clinician-rated to parent-rated because we were not able to collect clinician-rated sleep quality information).
  • Study Aim 3 - To determine the tolerability of the Sound To Sleep System™ as defined by study drop-out due to any reason and caregiver ratings of ease of mattress technology use.
  • Study Aim 4 - To determine whether use of the mattress technology improves functioning as defined by secondary outcome measures.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2014

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

July 21, 2014

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2016

Completed
2 months until next milestone

First Posted

Study publicly available on registry

April 15, 2016

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

November 6, 2017

Completed
Last Updated

November 6, 2017

Status Verified

October 1, 2017

Enrollment Period

1.6 years

First QC Date

July 21, 2014

Results QC Date

February 13, 2017

Last Update Submit

October 3, 2017

Conditions

Keywords

AutismASDSleepMattress

Outcome Measures

Primary Outcomes (1)

  • Compare Percentage of Participants Who Drop Out of Study as a Measure of Toleration of Mattress Technology

    Compare percentage of drop-out, in this cohort, due to issues with the mattress technology (e.g. ease of use, inability to fall asleep) to a population expected drop-out rate of 30% using a one-sample proportion test.

    up to 6 weeks

Secondary Outcomes (17)

  • Parent Reported Quality of Sleep Across Treatment Conditions

    Average daily score, across up to 2 weeks

  • Total Time Asleep Recorded by Actigraphy Watch

    Average of daily measure, across up to 2 weeks

  • Total Time to Fall Asleep (Sleep Latency) Recorded by Actigraphy Watch

    Average of daily measure, across up to 2 weeks

  • Total Time Awake During Night Recorded by Actigraphy Watch

    Average of daily measure, across up to 2 weeks

  • Percentage of Time in Bed That the Participant Spent Sleeping (Sleep Efficiency) Recorded by Actigraphy Watch.

    Average of daily measure, across up to 2 weeks

  • +12 more secondary outcomes

Study Arms (2)

Mattress Technology On then Off

EXPERIMENTAL

Intervention: Sound to Sleep System will be turned on for the first two weeks of the study allowing the participant sleeping atop the mattress to feel the vibrations synced to the audio input. Sound to sleep system will be turned on during this phase of the study. The sound to sleep system will sync an audio input with the vibrations of the mattress technology and allow the user to control the intensity of the vibration. No intervention: The mattress technology will be turned off for the second two weeks of the study. During this time, there will be no intervention.

Device: Sound to Sleep System

Mattress Technology Turned Off then On

EXPERIMENTAL

No intervention: For the first two weeks of the study, the mattress technology will not be turned off. There will be no intervention during this time. Intervention: Sound to Sleep System will be turned on for the second two weeks of the study allowing the participant sleeping atop the mattress to feel the vibrations synced to the audio input. Sound to sleep system will be turned on during this phase of the study. The sound to sleep system will sync an audio input with the vibrations of the mattress technology and allow the user to control the intensity of the vibration.

Device: Sound to Sleep System

Interventions

Sound to Sleep System is a minimal risk device that is embedded in a mattress boxspring. The device syncs with an audio input and emits tactile vibrations in sync with the audio input.

Mattress Technology On then OffMattress Technology Turned Off then On

Eligibility Criteria

Age30 Months - 13 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • ASD Diagnosis
  • Years of Age
  • Sleep Difficulty as indicated by significant sleep disturbance on the Child Sleep Habits Questionnaire
  • If participant is using medication or attends therapy, it must be stable four (4) weeks prior to their study participation and throughout the 5-6 week study period.

You may not qualify if:

  • Age less than 2.5 years or more than 12.99 years
  • Individuals who may have medication or therapy changes 4 weeks prior to study start date or during the study period
  • An participant diagnosed with epilepsy, Fragile X, Downs Syndrome, seizure disorder, Neurofibromatosis, or Tuberous Sclerosis
  • Any child with a pacemaker or other electrical device

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cleveland Clinic Center for Autism

Cleveland, Ohio, 44104, United States

Location

MeSH Terms

Conditions

Autism Spectrum DisorderAutistic Disorder

Condition Hierarchy (Ancestors)

Child Development Disorders, PervasiveNeurodevelopmental DisordersMental Disorders

Results Point of Contact

Title
Dr. Thomas Frazier
Organization
The Cleveland Clinic

Study Officials

  • Thomas Frazier, PhD

    The Cleveland Clinic

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Thomas W. Frazier, Ph.D

Study Record Dates

First Submitted

July 21, 2014

First Posted

April 15, 2016

Study Start

May 1, 2014

Primary Completion

December 1, 2015

Study Completion

February 1, 2016

Last Updated

November 6, 2017

Results First Posted

November 6, 2017

Record last verified: 2017-10

Data Sharing

IPD Sharing
Will not share

Locations